Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Acquires Rights To TRPV-1 Receptor Antagonists From Glenmark

Oct 31 2007

• By PharmAsia News

Related Content

Lilly Inks R&amp;D Deal With Indian Firm Potentially Worth $100 Million

Jan 12 2007

Renovis Gains Funding From Pfizer To Further VR1 Receptor Research

Apr 10 2007

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window